Accolade Inc
NASDAQ:ACCD
Accolade Inc
Total Equity
Accolade Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Accolade Inc
NASDAQ:ACCD
|
Total Equity
$313m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Equity
$7.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Equity
$75.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Cigna Corp
NYSE:CI
|
Total Equity
$41.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
13%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Equity
$8.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
6%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Total Equity
-$99.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Accolade Inc
Glance View
Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.
See Also
What is Accolade Inc's Total Equity?
Total Equity
313m
USD
Based on the financial report for Nov 30, 2024, Accolade Inc's Total Equity amounts to 313m USD.
What is Accolade Inc's Total Equity growth rate?
Total Equity CAGR 3Y
-27%
Over the last year, the Total Equity growth was -28%. The average annual Total Equity growth rates for Accolade Inc have been -27% over the past three years .
